Filters
reset allOther countries
Tests names and labs | Conditions | Genes, analytes, and microbes | Methods |
---|---|---|---|
Quantitative Genomic Medicine Laboratories, SL Spain | 184 | 162 |
|
Quantitative Genomic Medicine Laboratories, SL Spain | 184 | 162 |
|
Quantitative Genomic Medicine Laboratories, SL Spain | 184 | 162 |
|
High-Resolution Rapid Microarray (CGH and SNP) Allele Diagnostics United States | 247 | 231 |
|
Rapid microarray (CGH and SNP) Allele Diagnostics United States | 247 | 231 |
|
Quantitative Genomic Medicine Laboratories, SL Spain | 184 | 162 |
|
RUNX2 - NGS including CNV analysis Centogene AG - the Rare Disease Company Germany | 2 | 1 |
|
Centogene AG - the Rare Disease Company Germany | 498 | 498 |
|
Centogene AG - the Rare Disease Company Germany | 499 | 499 |
|
Invitae Skeletal Disorders Panel Invitae United States | 624 | 349 |
|
Intergen Intergen Genetics and Rare Diseases Diagnosis Center Turkey | 1 | 1 |
|
Cleidocranial dysplasia, 119600, Autosomal dominant (Cleidocranial dysplasia) (MLPA) Intergen Intergen Genetics and Rare Diseases Diagnosis Center Turkey | 1 | 1 |
|
Quantitative Genomic Medicine Laboratories, SL Spain | 184 | 162 |
|
Cleidocranial dysplasia Deletion / Duplication Test HNL Genomics Connective Tissue Gene Tests United States | 1 | 1 |
|
Cleidocranial dysplasia Comprehensive Test HNL Genomics Connective Tissue Gene Tests United States | 1 | 1 |
|
Spondylo-Epi-Metaphyseal dysplasias Comprehensive panel HNL Genomics Connective Tissue Gene Tests United States | 79 | 54 |
|
Spondylo-Epi-Metaphyseal dysplasias Deletion / Duplication panel HNL Genomics Connective Tissue Gene Tests United States | 79 | 54 |
|
Skeletal Disorders and Joint Problems Panel PreventionGenetics United States | 11 | 1 |
|
Genetic Services Laboratory University of Chicago United States | 31 | 35 |
|
Cleidocranial Dysplasia (CCD) via the RUNX2 Gene PreventionGenetics United States | 2 | 1 |
|
IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.